Juglanthraquinone C, a novel natural compound derived from Juglans mandshurica Maxim, induces S phase arrest and apoptosis in HepG2 cells

Apoptosis

Volumn 17, Issue 8, 2012, Pages 832-841

  Yao, Yao ^a   Zhang, Yu Wei ^a   Sun, Lu Guo ^a   Liu, Biao ^b   Bao, Yong Li ^a   Lin, Hua ^a   Zheng, Yu ^a   Zheng, Li Hua ^a   Sun, Ying ^a   Yu, Chun Lei ^a   Wu, Yin ^a   Wang, Guan Nan ^a   Li, Yu Xin ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Cytotoxicity; HepG2; Juglanthraquinone C; S phase arrest

Indexed keywords

1,5 DIHYDROXY 9,10 ANTHRAQUINONE 3 CARBOXYLIC ACID; ALOE EMODIN; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CHRYSOPHANIC ACID; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; EMODIN; JUGLANTHRAQUINONE C; KI 67 ANTIGEN; NATURAL PRODUCT; PHYSCION; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; RHEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BARK; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IC 50; JUGLANS MANDSHURICA; MEDICINAL PLANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; WALNUT;

ANTHRAQUINONES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL SURVIVAL; DRUGS, CHINESE HERBAL; ENZYME ACTIVATION; HEP G2 CELLS; HUMANS; JUGLANS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; S PHASE CELL CYCLE CHECKPOINTS; STRUCTURE-ACTIVITY RELATIONSHIP;

ALOE; JUGLANS MANDSHURICA;

EID: 84865120370     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-012-0722-5     Document Type: Article

References (36)

1. Min BS, Lee SY, Kim JH, Lee JK, Kim TJ, Kim DH, Kim YH, Joung H, Lee HK, Nakamura N, Miyashiro H, Hattori M (2003) Anti-complement activity of constituents from the stem-bark of Juglans mandshurica. Biol Pharm Bull 26:1042-1044 (Pubitemid 41685438)
2. Li G, Lee SY, Lee KS, Lee SW, Kim SH, Lee SH, Lee CS, Woo MH, Son JK (2003) DNA topoisomerases I and II inhibitory activity of constituents isolated from Juglans mandshurica. Arch Pharm Res 26:466-470 (Pubitemid 43073815)
3. Kim SH, Lee KS, Son JK, Je GH, Lee JS, Lee CH, Cheong CJ (1998) Cytotoxic compounds from the roots of Juglans mandshurica. J Nat Prod 61:643-645
4. Lee KS, Li G, Kim SH, Lee CS, Woo MH, Lee SH, Jhang YD, Son JK (2002) Cytotoxic diarylheptanoids from the roots of Juglans mandshurica. J Nat Prod 65:1707-1708 (Pubitemid 35386813)
5. Min BS, Nakamura N, Miyashiro H, Kim YH, Hattori M (2000) Inhibition of human immunodeficiency virus type 1 reverse transcriptase and ribonuclease H activities by constituents of Juglans mandshurica. Chem Pharm Bull (Tokyo) 48:194-200 (Pubitemid 30136938)
6. Min BS, Lee HK, Lee SM, Kim YH, Bae KH, Otake T, Nakamura N, Hattori M (2002) Anti-human immunodeficiency virus-type 1 activity of constituents from Juglans mandshurica. Arch Pharm Res 25:441-445 (Pubitemid 43057285)
7. Li G, Xu ML, Choi HG, Lee SH, Jahng YD, Lee CS, Moon DC, Woo MH, Son JK (2003) Four new diarylheptanoids from the roots of Juglans mandshurica. Chem Pharm Bull (Tokyo) 51:262-264
8. Han L, Li W, Narimatsu S, Liu L, Fu H, Okuda H, Koike K (2007) Inhibitory effects of compounds isolated from fruit of Juglans mandshurica on pancreatic lipase. J Nat Med 61:184-186
9. Lin H, Zhang YW, Zheng LH, Meng XY, Bao YL, Wu Y, Yu CL, Huang YX, Li YX (2011) Anthracene and anthraquinone derivatives from the stem bark of Juglans mandshurica Maxim. Helv Chim Acta 94:1488-1495
10. Zhang Y, Zhou L, Bao YL, Wu Y, Yu CL, Huang YX, Sun Y, Zheng LH, Li YX (2010) Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem Biol Interact 185:174-181
11. Tounekti O, Belehradek J, Mir LM (1995) Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res 217:506-516
12. Chen TF, Wong YS (2008) Selenocysteine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation. J Agric Food Chem 56:10574-10581
13. Seim J, Graff P, Amellem O, Landsverk KS, Stokke T, Pettersen EO (2003) Hypoxia-induced irreversible S-phase arrest involves down-regulation of cyclin A. Cell Prolif 36:321-332 (Pubitemid 37500133)
14. Zhu H, Zhang L,WuS, Teraishi F, Davis JJ, Jacob D, FangB(2004) Induction of S-phase arrest and p21 overexpression by a small molecule 2-[[3-(2,3-dichlorophenoxy)propyl]amino]ethanol in correlation with activation of ERK. Oncogene 23:4984-4992 (Pubitemid 38938731)
15. Debatin KM (2004) Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 53:153-159
16. Aouida M, Mekid H, Belhadj O, Mir LM, Tounekti O (2007) Mitochondria-independent morphological and biochemical apoptotic alterations promoted by the anti-tumor agent bleomycin in Saccharomyces cerevisiae. Biochem Cell Biol 85:49-55 (Pubitemid 46877387)
17. Broker LE, Kruyt FA, Giaccone G (2005) Cell death independent of caspases: a review. Clin Cancer Res 11:3155-3162 (Pubitemid 40627860)
18. Siegel RM (2006) Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 6:308-317
19. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312-1316 (Pubitemid 28406817)
20. Los M, Wesselborg S, Schulze-Osthoff K (1999) The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 10:629-639 (Pubitemid 29302916)
21. Degen WG, Pruijn GJ, Raats JM, van Venrooij WJ (2000) Caspase-dependent cleavage of nucleic acids. Cell Death Differ 7:616-627 (Pubitemid 30456167)
22. Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424 (Pubitemid 29449198)
23. Slee EA, Adrain C, Martin SJ (1999) Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ 6:1067-1074
24. Utz PJ, Anderson P (2000) Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Differ 7:589-602 (Pubitemid 30456165)
25. Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36:131-149 (Pubitemid 36808270)
26. Schafer KA (1998) The cell cycle: a review. Vet Pathol 35:461-478 (Pubitemid 128472819)
27. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770-776
28. Kaufmann SH, Hengartner MO (2001) Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11:526-534 (Pubitemid 33079147)
29. Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153-164 (Pubitemid 34161136)
30. Green DR, Reed JC (1998) Mitochondria and Apoptosis. Science 281:1309-1312 (Pubitemid 28406816)
31. Antonsson B (2001) Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion. Cell Tissue Res 306:347-361 (Pubitemid 33139893)
32. Murray A (1995) Cyclin ubiquitination: the destructive end of mitosis. Cell 81:149-152
33. Antonsson B, Martinou JC (2000) The Bcl-2 protein family. Exp Cell Res 256:50-57 (Pubitemid 30211166)
34. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387:773-776 (Pubitemid 27270895)
35. Vander Heiden MG, Thompson CB (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1:E209-E216 (Pubitemid 129503663)
36. Mayer B, Oberbauer R (2003) Mitochondrial regulation of apoptosis. News Physiol Sci 18:89-94 (Pubitemid 36782796)